Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elaine Sperin
Institution:
Emory University
Observed institutions:
Emory University,
Albany Medical College,
University of Rochester
OpenAlex ID:
A5000577229
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease
2016
·
Huntington Study Group
, Samuel Frank
, et al.
·
JAMA
·
403
PDF
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
2012
·
J.-M. Lee
, E.M. Ramos
, et al.
·
Neurology
·
382
Motor, cognitive, and functional declines contribute to a single progressive factor in early HD
2017
·
Scott A. Schobel
, Giuseppe Palermo
, et al.
·
Neurology
·
155
PDF
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
2016
·
Andrew McGarry
, Michael McDermott
, et al.
·
Neurology
·
139
PDF
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
2023
·
Erin Furr Stimming
, Daniel O Claassen
, et al.
·
The Lancet Neurology
·
67
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease A Randomized Clinical Trial
2016
·
Samuel Frank
, Claudia Testa
, et al.
·
Publisher
·
45
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
2022
·
Samuel Frank
, Claudia Testa
, et al.
·
CNS Drugs
·
33
PDF
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical Trial
2020
·
Michael J. Brownstein
, Neal G. Simon
, et al.
·
Journal of Clinical Medicine
·
30
PDF
Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia
2018
·
Laura M. Scorr
, Michael R. Silver
, et al.
·
Neurotherapeutics
·
11
PDF
Recruitment strategies for the racial disparities in Parkinson's disease study: Partnering with patients from the Black community
2025
·
Jacqueline Vanegas
, Jacqueline Vanegas
, et al.
·
Parkinsonism & Related Disorders
·
1
Prospective, Single-blind, pilot trial of AbobotulinumtoxinA (AboA) in oromandibular dystonia (OMD) (P3.017)
2017
·
Stewart Factor
, Michael Silver
, et al.
·
Neurology
Show more works
View as search
Works count:
12
Citation count:
1,420
H-index:
10
I10-index:
10
Year
Topic
Type